Skip to content
Join our MD program to become a physician with compassion, a sense of self, and true grit in all medical pursuits.
VP&S continues to be a world leader across the entire spectrum of basic science, translational, and clinical research
Our mission is to provide world-class patient care, foster innovative research, and train the next generation of leaders in medicine.
Showing 1 - 10 of 19 results.
5th International Workshop on Clinical Immune Tolerance was held April 28-29, 2022 in Jersey City, New Jersey, produced by CUIMC, Dept of Medicine and the CCTI on behalf of the Organizing Committee.
“Xenotransplantation is the future, and always will be.”
Dr. Yamada has received an award from Wiley for Top Cited Article, 2020-2021.
Dr. Nichole Danzl, et al. aimed to generate human thymic epithelial progenitors from human embryonic stem cells (hES-TEPs) and to assess their thymopoietic function in vivo.
This years IXA-CTRMS Joint Congress will be virtual. Dr. Megan Sykes, CCTI Director, will co-chair the Women in Science and Research discussion.
Dr. Pawel Muranski, MD, CCTI Principal Investigator, discusses what’s known and unknown about COVID vaccines and the immunocompromised.
The official journal of The Transplantation Society profiled Dr. David H. Sachs, MD, Professor of Surgery and CCTI principal investigator, and his 50+ year career in academic research and education.
CCTI research fellow Dr. Karina Bruestle Chosen for several presentations and travel award at ATC 2021.
Megan Sykes, MD, in the Department of Medicine in the Columbia Center for Translational Immunology, has been selected as a Distinguished Fellow by the American Association of Immunologists.
Dr. Ran Reshef, director of the CAR T-cell program at the HICCC, discusses a promising type of treatment called chimeric antigen receptor (CAR) T-cell therapy.